Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

4.76
BATS BZX Real-Time Price
As of 2:53pm ET
 -0.19 / -3.84%
Today’s Change
4.66
Today|||52-Week Range
12.88
-49.31%
Year-to-Date
No recent news for Pernix Therapeutics Holdings Inc.

Today’s Trading

Previous close4.95
Today’s open4.92
Day’s range4.74 - 5.02
Volume832,643
Average volume (3 months)1,161,037
Market cap$215.5M
Dividend yield--
Data as of 2:38pm ET, 08/04/2015

Growth & Valuation

Earnings growth (last year)-32.86%
Earnings growth (this year)-49.73%
Earnings growth (next 5 years)+13.60%
Revenue growth (last year)+43.45%
P/E ratioNM
Price/Sales2.92
Price/Book2.27

Competitors

 Today’s
change
Today’s
% change
ECYTEndocyte Inc+0.11+2.15%
ALIMAlimera Sciences Inc-0.05-1.05%
VTAEVitae Pharmaceutical...-0.03-0.31%
HSKAHeska Corp+0.79+2.31%
Data as of 2:53pm ET, 08/04/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)-$0.43
Annual revenue (last year)$121.7M
Annual profit (last year)-$35.3M
Net profit margin-28.98%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Douglas L. Drysdale
Chief Operating Officer
Terence S. Novak
Corporate headquarters
Morristown, New Jersey

Forecasts